nxn-188
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2009 (NCT00877838)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Nitric-oxide synthase, brainINHIBITOR
NOS1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nxn-188
- nxn-188
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00959751 | Phase 2 | Jul 1, 2009 | NeurAxon Inc., University of Montreal |
| NCT00920686 | Phase 2 | Jun 1, 2009 | NeurAxon Inc., University of Montreal |
| NCT00877838 | Phase 2 | May 1, 2009 | NeurAxon Inc., University of Copenhagen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NeurAxon Inc. | For profit | 3 | 2 | 1 | 2009 |
| University of Montreal | Academic/Hospital | 2 | 0 | 1 | 2009 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2009 |
3 organizations
Page 1 / 1